[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate

C68H97N7O15 — CID 159873739

IUPAC[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate
SMILESCO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)CCc3cnc(N4CCN(c5ncc(C(C)=O)cn5)CC4)nc3)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C\C=C\C=C\1C
InChIInChI=1S/C68H97N7O15/c1-41-17-13-12-14-18-42(2)56(85-9)35-52-23-20-47(7)68(84,90-52)63(81)64(82)75-26-16-15-19-53(75)65(83)89-57(36-54(77)43(3)32-46(6)61(80)62(87-11)60(79)45(5)31-41)44(4)33-49-21-24-55(58(34-49)86-10)88-59(78)25-22-50-37-69-66(70-38-50)73-27-29-74(30-28-73)67-71-39-51(40-72-67)48(8)76/h12-14,17-18,32,37-41,43-45,47,49,52-53,55-58,61-62,80,84H,15-16,19-31,33-36H2,1-11H3/b14-12+,17-13-,42-18+,46-32+/t41-,43-,44-,45-,47-,49+,52+,53+,55-,56+,57+,58-,61-,62+,68-/m1/s1
InChIKeyRJPCGOZRMPLBIY-UVJPEEKVSA-N
MW1252.56 g/mol
LogP7.47
Rot. Bonds13

About [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate

[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate (PubChem CID 159873739) has the molecular formula C68H97N7O15 and a molecular weight of 1252.56 g/mol. Its IUPAC name is [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate.

Molecular Properties

Compound Name[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate
PubChem CID159873739
Molecular FormulaC68H97N7O15
Molecular Weight1252.56 g/mol
Exact Mass1251.70
IUPAC Name[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate
SMILESCO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)CCc3cnc(N4CCN(c5ncc(C(C)=O)cn5)CC4)nc3)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C\C=C\C=C\1C
InChIInChI=1S/C68H97N7O15/c1-41-17-13-12-14-18-42(2)56(85-9)35-52-23-20-47(7)68(84,90-52)63(81)64(82)75-26-16-15-19-53(75)65(83)89-57(36-54(77)43(3)32-46(6)61(80)62(87-11)60(79)45(5)31-41)44(4)33-49-21-24-55(58(34-49)86-10)88-59(78)25-22-50-37-69-66(70-38-50)73-27-29-74(30-28-73)67-71-39-51(40-72-67)48(8)76/h12-14,17-18,32,37-41,43-45,47,49,52-53,55-58,61-62,80,84H,15-16,19-31,33-36H2,1-11H3/b14-12+,17-13-,42-18+,46-32+/t41-,43-,44-,45-,47-,49+,52+,53+,55-,56+,57+,58-,61-,62+,68-/m1/s1
InChIKeyRJPCGOZRMPLBIY-UVJPEEKVSA-N
XLogP7.47
TPSA276.61 Ų
H-Bond Donors2
H-Bond Acceptors21
Rotatable Bonds13
Heavy Atoms90
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001252.56
LogP ≤ 57.47
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate?
The IUPAC name of [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate (CID 159873739) is [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate.
What is the SMILES notation for [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate?
The canonical SMILES for [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate is CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)CCc3cnc(N4CCN(c5ncc(C(C)=O)cn5)CC4)nc3)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C\C=C\C=C\1C.
What is the InChIKey of [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate?
The InChIKey is RJPCGOZRMPLBIY-UVJPEEKVSA-N. The full InChI is InChI=1S/C68H97N7O15/c1-41-17-13-12-14-18-42(2)56(85-9)35-52-23-20-47(7)68(84,90-52)63(81)64(82)75-26-16-15-19-53(75)65(83)89-57(36-54(77)43(3)32-46(6)61(80)62(87-11)60(79)45(5)31-41)44(4)33-49-21-24-55(58(34-49)86-10)88-59(78)25-22-50-37-69-66(70-38-50)73-27-29-74(30-28-73)67-71-39-51(40-72-67)48(8)76/h12-14,17-18,32,37-41,43-45,47,49,52-53,55-58,61-62,80,84H,15-16,19-31,33-36H2,1-11H3/b14-12+,17-13-,42-18+,46-32+/t41-,43-,44-,45-,47-,49+,52+,53+,55-,56+,57+,58-,61-,62+,68-/m1/s1.
What are the key properties of [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate?
[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate has a molecular weight of 1252.56 g/mol, XLogP of 7.47, 13 rotatable bonds, 2 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-[2-[4-(5-acetylpyrimidin-2-yl)piperazin-1-yl]pyrimidin-5-yl]propanoate is sourced from PubChem (CID 159873739), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).